awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37214534-245E6DF6-830A-4B21-BBCF-73C67D932B4F
Q37214534-245E6DF6-830A-4B21-BBCF-73C67D932B4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37214534-245E6DF6-830A-4B21-BBCF-73C67D932B4F
CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.
P2860
Q37214534-245E6DF6-830A-4B21-BBCF-73C67D932B4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37214534-245E6DF6-830A-4B21-BBCF-73C67D932B4F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3419d5054151d8ac93bb07ff7ab15289c1e1f57e
P2860
Update: peripheral T-cell lymphomas.